compar
sarscov
merscov
epidem
coronaviru
rapidli
spread
part
world
countri
territori
last
updat
march
symptomat
patient
clinic
manifest
diseas
usual
start
less
week
consist
fever
bodi
temperatur
cough
nasal
congest
fatigu
pneumonia
mostli
occur
second
third
week
symptomat
infect
comparison
hematolog
paramet
mild
sever
case
show
signific
differ
ddimer
glucos
glu
thrombin
time
tt
fibrinogen
fib
creactiv
protein
crp
fan
et
al
analyz
hematolog
indic
infect
patient
intens
care
unit
icu
patient
show
lymphopenia
rais
lactat
dehydrogenas
ldh
associ
higher
rate
icu
admiss
patient
transfer
icu
lower
nadir
lymphocyt
count
nadir
monocyt
count
nadir
hemoglobin
higher
peak
neutrophil
neu
count
peak
ldh
level
compar
patient
requir
icu
stay
mani
patient
merscov
liver
function
abnorm
elev
alanin
aminotransferas
alt
aspart
aminotransferas
ast
ldh
also
laboratori
data
sar
shown
patient
elev
crp
level
lymphopenia
leukopenia
elev
level
aminotransferas
ldh
creatin
kinas
seri
recent
publish
articl
report
epidemiolog
clinic
characterist
patient
diseas
data
regard
laboratori
characterist
infect
individu
limit
studi
aim
evalu
accuraci
laboratori
paramet
predict
case
posit
rtpcr
studi
design
set
diagnost
accuraci
studi
conduct
suspect
patient
present
behpooyan
clinic
medic
center
tehran
iran
februari
march
patient
divid
two
group
base
result
real
time
revers
chain
reaction
rtpcr
accuraci
differ
laboratori
paramet
predict
case
posit
rtpcr
evalu
use
area
roc
curv
auc
studi
protocol
approv
ethic
committe
shahid
beheshti
univers
medic
scienc
ethic
code
particip
outpati
suspect
initi
respiratori
sign
includ
sore
throat
without
short
breath
fever
cough
muscl
ach
headach
includ
data
gather
pharyng
swab
sampl
collect
test
present
blood
sampl
collect
particip
routin
blood
test
includ
white
blood
cell
count
wbc
lymphocyt
count
lym
neutrophil
count
neu
perform
blood
sampl
furthermor
blood
biochemistri
paramet
aspart
aminotransferas
ast
alanin
aminotransferas
alt
urea
creactiv
protein
crp
well
albumin
lactat
dehydrogenas
ldh
assess
use
hitachi
autom
biochemistri
analyz
statist
analysi
data
urea
wbc
albumin
ast
alt
ldh
level
express
mean
standard
deviat
sd
differ
level
urea
crp
wbc
lym
neu
albumin
ast
alt
ldh
rtpcr
posit
neg
patient
assess
use
student
ttest
receiv
oper
characterist
roc
curv
auc
use
analyz
optim
cutoff
predict
posit
rtpcr
case
studi
auc
defin
excel
accuraci
good
good
suffici
bad
poor
useless
test
characterist
studi
case
two
hundr
case
mean
age
rang
year
studi
male
case
year
age
rang
result
rtpcr
posit
case
neg
group
patient
posit
neg
rtpcr
similar
regard
gender
p
age
p
distribut
laboratori
paramet
tabl
compar
laboratori
paramet
patient
posit
neg
rtpcr
patient
posit
rtpcr
significantli
higher
neu
count
p
crp
p
ldh
p
ast
p
alt
p
urea
p
level
serum
addit
patient
posit
rtpcr
lower
wbc
count
p
serum
albumin
level
p
compar
other
tabl
figur
show
area
roc
curv
studi
paramet
predict
case
posit
rtpcr
alt
auc
crp
auc
neu
auc
ldh
auc
urea
good
accuraci
predict
case
posit
rtpcr
respect
base
find
studi
alt
crp
neu
ldh
urea
good
accuraci
predict
case
posit
rtpcr
respect
chen
et
al
found
ldh
significantli
increas
patient
albumin
decreas
alt
ast
show
signific
chang
mention
valu
also
report
patient
merscov
elev
alt
ast
ldh
observ
anoth
studi
indic
patient
liver
comorbid
case
abnorm
alt
ast
level
progress
diseas
furthermor
shi
et
al
studi
patient
whose
diagnosi
confirm
comput
tomographi
ct
scan
subclin
phase
found
incid
ast
abnorm
among
patient
significantli
lower
diagnos
onset
symptom
therefor
liver
injuri
preval
sever
case
compar
mild
case
anoth
report
yang
et
al
found
differ
incid
abnorm
liver
function
survivor
nonsurvivor
liver
damag
mild
case
often
transient
return
normal
without
special
treatment
found
number
percentag
wbc
lym
neu
significantli
differ
posit
neg
rtpcr
case
comparison
normal
rang
found
low
wbc
lym
count
patient
posit
rtpcr
wherea
neu
count
higher
patient
previou
report
low
lym
wbc
count
found
patient
line
studi
laboratori
studi
show
leucopenia
leukocyt
count
cellsl
neu
therefor
result
suggest
neu
might
affect
initi
phase
diseas
also
suggest
might
mainli
act
lymphocyt
especi
lymphocyt
sarscov
viru
particl
spread
respiratori
tract
infect
cell
induc
seri
immun
respons
caus
chang
number
peripher
white
blood
cell
lymphocyt
studi
suggest
substanti
decreas
total
number
lymphocyt
indic
coronaviru
affect
mani
immun
cell
inhibit
cellular
immun
function
tsui
other
report
high
neutrophil
count
admiss
patient
elev
ldh
level
independ
predictor
advers
clinic
outcom
present
studi
roc
curv
use
analyz
specif
sensit
differ
variabl
suspect
patient
auc
laboratori
paramet
alt
crp
ast
ldh
neu
indic
could
use
predict
presenc
diseas
albumin
wbc
refer
line
roc
curv
indic
poor
predictor
diseas
data
line
result
report
wang
et
al
gao
et
al
current
studi
auc
crp
alt
ldh
urea
neu
thu
effect
good
predict
valu
predict
seem
blood
laboratori
paramet
could
use
screen
case
posit
rtpcr
consid
signific
differ
laboratori
paramet
evalu
studi
group
one
hope
model
predict
result
coronaviru
test
base
routin
laboratori
test
sampl
size
rel
small
addit
sinc
studi
conduct
blood
laboratori
paramet
everi
patient
continu
monitor
clinic
manifest
base
find
studi
alt
crp
neu
ldh
urea
good
accuraci
predict
case
posit
rtpcr
respect
